Table 5 Urinary tDON and tDOM-1 by gender and age groups.
Compound | Positive | Mean (± SD) | Median | Range | |
|---|---|---|---|---|---|
n (%) | ng mL−1 | ng mL−1 | ng mL−1 | ||
Gender | Male, n = 56 | ||||
tDON | 56 (100%) | 38.8 (±32.2) | 29.8 | 3.11–132 | |
fDON | 49 (87.5%) | 5.96 (±6.03) | 4.25 | ND–25.2 | |
tDOM-1 | 14 (25.0%) | 0.37 (±1.08) | 0.05 | ND–6.43 | |
Female, n = 95 | |||||
tDON | 95 (100%) | 52.8 (±56.5) | 33.4 | 1.36–247 | |
fDON | 91 (95.8%) | 9.60 (±9.78) | 6.47 | ND–47.0 | |
tDOM-1 | 32 (33.7%) | 0.22 (±0.54) | 0.05 | ND–3.49 | |
Age | Age ≤ 12, n = 33 | ||||
tDON | 33 (100%) | 63.2 (±52.6) | 44.6 | 7.42–224 | |
fDON | 32 (97.0%) | 11.3 (±10.5) | 7.79 | ND–47.0 | |
tDOM-1 | 12 (36.4%) | 0.16 (±0.25) | 0.05 | ND–1.05 | |
12 < Age ≤ 18, n = 14 | |||||
tDON | 14 (100%) | 73.1 (±61.0) | 52.4 | 11.4–240 | |
fDON | 14 (100%) | 13.0 (±10.8) | 9.85 | 1.00–37.4 | |
tDOM-1 | 5 (35.7%) | 0.11 (±0.10) | 0.05 | ND–0.35 | |
18 < Age ≤ 65, n = 68 | |||||
tDON | 68 (100%) | 45.1 (±44.5) | 29.8 | 3.31–213 | |
fDON | 65 (95.6%) | 8.05 (±7.38) | 5.79 | ND–31.1 | |
tDOM-1 | 21 (30.9%) | 0.36 (±1.03) | 0.05 | ND–6.43 | |
Age > 65, n = 36 | |||||
tDON | 36 (100%) | 27.8 (±42.2) | 10.98 | 1.36–247 | |
fDON | 29 (80.6%) | 3.96 (±6.49) | 2.48 | ND–37.0 | |
tDOM-1 | 8 (22.2%) | 0.40 (±0.74) | 0.05 | ND–2.91 | |
